MP-17 cosmetic peptide suspension · choose base, strength, and preservation
The INCI peptide found in supplier-branded Xlash / SymPeptide Xlash lash-care actives. We supply our own 0.1% (1X) and 1% (10X) suspensions; we do not sell or represent those trade names.
Myristoyl-Gly-His-Lys-Arg-His-Arg · CAS 959610-30-1
Myristoyl Pentapeptide-17 is a myristoylated pentapeptide used in cosmetic lash-, brow-, and scalp-care serums. Published cosmetic studies evaluate keratin-supporting sequences in topical leave-on formats for the look of longer, fuller lashes and thicker-looking brows. Use cosmetic structure / function language only; do not make lash-growth drug claims.
Market context: this is the INCI peptide found in supplier-branded Xlash / SymPeptide Xlash (Lubrizol) actives. Formulate Labs supplies Myristoyl Pentapeptide-17 in our own made-to-order suspensions. We do not sell, stock, or represent those trade names.
We supply it as a finished aqueous suspension at 0.1% standard (1X) or 1% lab concentrate (10X) in a 35% glycerin / water base or dosed into our single-origin Sea Kelp Bioferment.
These attributes are assessments based on the ingredient deck and the supplier information available to us. They are not third-party certifications (no Kosher, Halal, Vegan, or similar certifying body has audited or issued a certificate for this material). If your finished product requires a specific certified status, please reach out and we’ll walk through what we can document.
Every lot is produced to order in our AI-powered robotic factory. Nothing sits on a warehouse shelf going stale - you get a date-of-manufacture-fresh batch every time.
This product, Myristoyl Pentapeptide-17 (INCI), is a raw material for cosmetic formulation and is not a branded finished cosmetic product or a specific trade-name active.
Myristoyl Pentapeptide-17 is cited in published eyelash- and hair-care cosmetic studies evaluating keratin-supporting peptide sequences in topical serums. It is the INCI peptide found in supplier-branded Xlash / SymPeptide Xlash actives; we do not sell or represent those trade names. These are independent, third-party papers we link for formulators evaluating mechanism, tolerability, and published panel data. We did not conduct this research and do not guarantee replication in your finished formula.
Open-label clinical evaluation of an eyelash serum containing myristoyl pentapeptide-17 and supporting actives, reporting improvements in lash length, thickness, and volume.
Reviews cosmetic peptide applications including lash- and brow-care sequences and the structure/function claim framing for non-drug topicals.
Foundational cosmetic-peptide review covering how signal peptides are evaluated in finished topical products.
Clinician-oriented review of topical peptide cosmeceuticals, mechanisms, and the evidence base formulators use when selecting lash- and skin-active sequences.
These citations are provided for informational and formulation-research purposes only. Study designs, concentrations, vehicle systems, and populations vary and may not match the suspensions on this page. Published results do not constitute FDA or EU cosmetic claim substantiation for your brand. Always review the primary literature and consult your regulatory counsel before making structure/function statements on finished products.
This is the per-ingredient composition of the suspension as it ships. Updates dynamically when you change the base, strength, or preservation system above. The peptide line shows the MP-17 loading; the preservative line shows the supplier-blend percentage with its sub-ingredients nested below.
SDS + TDS are issued per recipe (each base / preservative combination has its own regulatory paperwork). The links below swap when you change your selection above. COA is batch-specific and ships with the order.
